Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
12 studies found for:    Kinex Pharmaceuticals Inc [Lead]
Show Display Options
Rank Status Study
1 Not yet recruiting Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers
Conditions: Gastric Cancer;   Esophageal Cancer;   Gastro-esophageal Cancer
Interventions: Drug: Oraxol;   Drug: Ramucirumab
2 Not yet recruiting A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies
Condition: Solid Tumor
Intervention: Drug: Oradoxel
3 Active, not recruiting A Ph2a, Open-Label, Multicenter, Activity&Safety Study of KX2-391 Oint in Subj. w Actinic Keratosis on the Face or Scalp
Condition: Actinic Keratosis
Intervention: Drug: KX2-391
4 Recruiting A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies
Condition: Solid Tumor
Intervention: Drug: Oraxol
5 Recruiting Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Oraxol;   Drug: IV paclitaxel
6 Completed Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Drug: KX2-391 Ointment
7 Recruiting Safety, Tolerability & PK of KX2-361 in Subjects w Adv. Malignancies Refractory to Conventional Therapies
Condition: Advance Malignancies
Intervention: Drug: KX2-361
8 Recruiting A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies
Condition: Solid Tumor
Intervention: Drug: Oratecan
9 Completed A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies
Condition: Solid Tumor
Intervention: Drug: Oraxol
10 Completed Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Condition: Acute Myelogenous Leukemia
Intervention: Drug: KX2-391
11 Completed A Safety and Efficacy Study of KX2-391 in Patients With Bone-Metastatic, Castration-Resistant Prostate Cancer Who Have Not Received Prior Chemotherapy
Condition: Bone-Metastatic, Castration-Resistant Prostate Cancer
Intervention: Drug: KX2-391
12 Completed Evaluation of KX2-391 in Patients With Advanced Malignancies
Conditions: Solid Tumors;   Lymphoma
Intervention: Drug: KX2-391

Study has passed its completion date and status has not been verified in more than two years.